The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma.

Respiratory Medicine(2012)

引用 16|浏览4
暂无评分
摘要
Leukotriene B4 (LTB4) is a potent inflammatory mediator in asthma, and is increased in more severe asthma. Targeting LTB4, in addition to cysteinyl leukotrienes, could be beneficial in asthma.
更多
查看译文
关键词
Asthma,Leukotrienes,5-Lipoxygenase
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要